Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2010
10/14/2010US20100260857 Enzyme delivery systems and methods of preparation and use
10/14/2010US20100260853 Compositions for pulmonary delivery
10/14/2010US20100260848 System for controlled release of an active principle and method for preparation
10/14/2010US20100260835 Pharmaceutical composition
10/14/2010US20100260831 Non-pegylated liposomal doxorubicin triple combination therapy
10/14/2010US20100260828 Modulation of Platelet Aggregation
10/14/2010US20100260827 Methods of diagnosing, preventing and treating cancer metastasis
10/14/2010US20100260825 Antifolates for the treatment of cardiovascular, inflammatory, neoplastic, autoimmune and related diseases in sublingual dosage units, film strips, or skin patches
10/14/2010US20100260824 Antimicrobial Foam Compositions, Articles and Methods
10/14/2010US20100260823 Preparation with marine collagen for protease inhibition
10/14/2010US20100260822 Surface protection of exposed biological tissues
10/14/2010US20100260819 Reducing post-operative adhesion formation with intraperitoneal glutamine
10/14/2010US20100260807 Methods of Inducing and/or Enhancing an Immune Response To Tumor Antigens
10/14/2010US20100260793 Defensin-antigen fusion proteins
10/14/2010US20100260791 Chlamydia antigens
10/14/2010US20100260787 Human sperm fibrous sheath (FS) proteins: new target antigens for use in therapeutic cancer vaccines and diagnostic screening and Methods of Using Same
10/14/2010US20100260781 Treatment methods for autoimmune disorders
10/14/2010US20100260780 Uniform field magnetization and targeting of therapeutic formulations
10/14/2010US20100260777 Treatment and/or prevention of sepsis using an enteral composition
10/14/2010US20100260774 Netrin-1 Compositions and Methods of Use Thereof
10/14/2010US20100260771 Method for Diagnosing the Metabolic Syndrome (MS)
10/14/2010US20100260770 Il-33 in inflammatory disease
10/14/2010US20100260767 Composition and Method for Treating Inflammatory Disorders
10/14/2010US20100260761 Antibodies specifically reactive with a tumor necrosis factor related ligand
10/14/2010US20100260758 In vivo modulation of neuronal transport
10/14/2010US20100260757 USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY
10/14/2010US20100260755 Ibudilast and immunomodulators combination
10/14/2010US20100260750 Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity
10/14/2010US20100260749 Modulators of EphA2 and Ephrin-A1 for the treatment of fibrosis-related disease
10/14/2010US20100260747 Use of Tetrahydrobiopterin as a Marker and a Therapeutic Agent for Fabry Disease
10/14/2010US20100260746 Novel Bank1 Splice Variant
10/14/2010US20100260741 Factor VII or VIIa Polypeptide Variants
10/14/2010US20100260740 Methods for preventing and/or treating lysosomal storage disorders
10/14/2010US20100260739 Mirac Proteins
10/14/2010US20100260738 Uses and methods relating to ndr kinase expression and/or activity
10/14/2010US20100260737 Combination between an isothiocyanate and levodopa for parkinson's disease treatment
10/14/2010US20100260736 Egr1 modulators for the treatment of alopecia
10/14/2010US20100260734 Method of stimulating prosaposin receptor activity
10/14/2010US20100260733 Novel anti aging agents and methods to identify them
10/14/2010US20100260726 Methods for Producing a Non Human Model for Aortic Aneurysm
10/14/2010US20100260723 Implantable system for an intervertebral disc and intervertebral disc implant
10/14/2010US20100260719 Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
10/14/2010US20100260718 Irf-4 as a tumor suppressor and uses thereof
10/14/2010US20100260717 Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection
10/14/2010US20100260716 Compounds for treating demyelination conditions
10/14/2010US20100260715 Hepatitis c virus inhibitors
10/14/2010US20100260714 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
10/14/2010US20100260713 Compositions and Methods for the Inhibition of Hepatitis C Viral Replication with Structural Analogs
10/14/2010US20100260712 Use of human antibody capable of neutralizing hepatitis b virus for the prevention or treatment of hepatitis b virus infection
10/14/2010US20100260711 3-aminosulfonyl substituted indole derivatives and methods of use thereof
10/14/2010US20100260710 Macrocyclic serine protease inhibitors
10/14/2010US20100260709 Organic compounds and their uses
10/14/2010US20100260708 Hepatitis C Virus Inhibitors
10/14/2010US20100260707 Antigen associated with rheumatoid arthritis
10/14/2010US20100260706 Compositions and methods for improving production of recombinant polypeptides
10/14/2010US20100260705 Products for altering il-33 activity and methods thereof
10/14/2010US20100260704 Human interferon-gamma (infgamma) variants
10/14/2010US20100260694 Methionine Sulfoxide Peptide, Compositions And Methods Of Use
10/14/2010US20100260681 Adrenocorticotropic hormone analogs and related methods
10/14/2010US20100260680 Novel bone mass increasing agent
10/14/2010US20100260676 Precision-guided nanoparticle systems for drug delivery
10/14/2010US20100260675 Oxytocin Receptor Antagonists and Their Use for the Treatment of Pulmonary Related Diseases
10/14/2010US20100260674 Quinazoline derivatives and methods of treatment
10/14/2010US20100260673 Phage display peptide probes for imaging early responses to antiangiogenic treatment
10/14/2010US20100260672 Peptides that specifically bind hgf receptor (cmet) and uses thereof
10/14/2010US20100260669 Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
10/14/2010CA2758322A1 Par-1 activation by metalloproteinase-1 (mmp-1)
10/14/2010CA2758264A1 Neuromedin u derivative
10/14/2010CA2758204A1 Immunogenic composition and uses thereof
10/14/2010CA2758103A1 Cyclic peptides with an anti-parasitic activity
10/14/2010CA2758072A1 Macrocyclic serine protease inhibitors
10/14/2010CA2757897A1 Human protein scaffold with controlled serum pharmacokinetics
10/14/2010CA2757645A1 Methods and materials for delivering molecules
10/14/2010CA2757287A1 Cytokines and neuroantigens for treatment of immune disorders
10/14/2010CA2757088A1 Neuron generation, regeneration and protection
10/14/2010CA2754807A1 Combination therapy of an afucosylated antibody and one or more of the cytokines selected from human gm-csf, human m-csf and/or human il-3
10/13/2010EP2239581A1 Phosphorylation of histone H3 at threonine 11 - a novel epigenetic mark for transcriptional regulation
10/13/2010EP2239340A2 Identification of surface-oriented antigens for tumour diagnosis and treatment
10/13/2010EP2239330A1 Neuron generation, regeneration and protection
10/13/2010EP2239274A1 New methods for diagnosis and treatment of tumours
10/13/2010EP2239272A2 Specific protein of the pancreatic beta cells of the Langerhans' islands and applications thereof
10/13/2010EP2239270A2 Low molecular weight peptide derivatives as inhibitors of the Laminin/Nidogen interaction
10/13/2010EP2239269A1 Use of peptides derived from copolymer-1 as molecular weight markers
10/13/2010EP2239268A1 Dipeptide derivatives
10/13/2010EP2238987A1 Sugar chain-related gene and use thereof
10/13/2010EP2238984A1 Caspasin inhibitor peptides
10/13/2010EP2238983A2 Neublastin variants
10/13/2010EP2238982A2 Therapeutic agent for soft tissue sarcoma
10/13/2010EP2238261A1 Isomerases, nucleic acids encoding them and methods for making and using them
10/13/2010EP2238242A1 Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them
10/13/2010EP2237794A2 Chimeric hiv fusion proteins as vaccines
10/13/2010EP2237793A1 Inhibitors of cathepsin b
10/13/2010EP2237771A1 Pharmaceutical compositions comprising granules of purified microbial lipase and methods of preventing or treating digestive disorders
10/13/2010EP1781284B1 Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma
10/13/2010EP1765381B1 Treatment of neurological disorders with haematopoietic growth factors
10/13/2010EP1716232B9 Acid alpha-glucosidase and fragments thereof
10/13/2010EP1553972B1 Chorionic gonadotropin for use in the treatment of chronic pelvic pain syndrome
10/13/2010EP1503785B1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
10/13/2010EP1102848B1 Molecules designated ldcam
10/13/2010EP1005526B1 Direct expression of peptides into culture media
1 ... 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 ... 3163